Oxygenta Pharmaceutical Ltd 25 May 2026 12:00 AM
Oxygenta Pharmaceutical reports standalone net loss of Rs 1.70 crore in the March 2026 quarter,
Net Loss of Oxygenta Pharmaceutical reported to Rs 1.70 crore in the quarter ended March 2026 as against net loss of Rs 2.15 crore during the previous quarter ended March 2025. Sales rose 0.28% to Rs 49.61 crore in the quarter ended March 2026 as against Rs 49.47 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 17.57 crore in the year ended March 2026 as against net loss of Rs 10.30 crore during the previous year ended March 2025. Sales rose 3.37% to Rs 112.98 crore in the year ended March 2026 as against Rs 109.30 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales49.6149.47 0 112.98109.30 3 OPM %0.24-3.40 --13.60-9.15 - PBDT-1.52-3.76 60 -19.86-10.47 -90 PBT-1.28-3.53 64 -22.18-14.08 -58 NP-1.70-2.15 21 -17.57-10.30 -71 Powered by Capital Market - Live News
Oxygenta Pharmaceutical Ltd 20 May 2026 12:00 AM
Oxygenta Pharmaceutical announces board meeting date,
Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 23 May 2026.
Oxygenta Pharmaceutical Ltd 05 Feb 2026 12:00 AM
Oxygenta Pharmaceutical reports standalone net loss of Rs 4.84 crore in the December 2025 quarter,
Net Loss of Oxygenta Pharmaceutical reported to Rs 4.84 crore in the quarter ended December 2025 as against net loss of Rs 3.93 crore during the previous quarter ended December 2024. Sales rose 2.17% to Rs 33.93 crore in the quarter ended December 2025 as against Rs 33.21 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales33.9333.21 2 OPM %-12.00-13.10 - PBDT-5.46-4.25 -28 PBT-6.32-4.96 -27 NP-4.84-3.93 -23 Powered by Capital Market - Live News
Oxygenta Pharmaceutical Ltd 31 Jan 2026 12:00 AM
Oxygenta Pharmaceutical schedules board meeting,
Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 4 February 2026.Powered by Capital Market - Live News
Oxygenta Pharmaceutical Ltd 08 Nov 2025 12:00 AM
Oxygenta Pharmaceutical reports standalone net loss of Rs 4.93 crore in the September 2025 quarter,
Net Loss of Oxygenta Pharmaceutical reported to Rs 4.93 crore in the quarter ended September 2025 as against net loss of Rs 2.85 crore during the previous quarter ended September 2024. Sales rose 2.07% to Rs 14.30 crore in the quarter ended September 2025 as against Rs 14.01 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales14.3014.01 2 OPM %-31.96-15.49 - PBDT-5.58-2.11 -164 PBT-6.44-2.77 -132 NP-4.93-2.85 -73 Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now